Leukemia News - ScienceDaily
2 天之前 · Read the latest medical research and information on leukemia. Learn about the symptoms and diagnosis of chronic myeloid leukemia (CML) and other leukemia types. What …
FDA Approves New Drug for the Most Common Form of Leukemia …
Rye Brook, N.Y., December 8, 2023 – The U.S. Food and Drug Administration has approved pirtobrutinib (Jaypirca™) for the treatment of adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has worsened or returned despite at least two earlier forms of treatment.
Blood Cancer News | Leukemia and Lymphoma Society
Our team of experts bringing you blood cancer-related news and updates. The U.S. Food and Drug Administration yesterday approved nelarabine injection, a critical treatment for T-cell acute lymphoblastic leukemia (T-ALL), an aggressive blood cancer that is most common in children.
FDA Approves New Targeted Treatment for Acute Myeloid Leukemia
Rye Brook, N.Y., July 25, 2023 – The U.S. Food and Drug Administration (FDA) last week approved quizartinib (Vanflyta®) in combination with standard chemotherapies for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) that carries a genetic mutation called FLT3-ITD.
Mitochondrial DNA plays an underappreciated role in leukemia ...
4 天之前 · Instead, the researchers used a leukemia mouse model with a defective genetic proofreading system called Polg, which gradually accrues mtDNA mutations. By disrupting Polg’s proofreading function in either one (heterozygous) or both (homozygous) parental lines, the researchers could look at the burden that mtDNA mutations place on tumor growth ...
Leukemia | Oncology & Cancer News | CURE - Curetoday
2024年12月24日 · CURE® highlights some top stories from the ASH Annual Meeting, focusing on B-cell acute lymphoblastic leukemia, multiple myeloma and other blood cancers. What treatments for leukemia and lymphoma are on the way?
New triplet therapies show promise for relapsed and newly …
2024年12月9日 · In November, the Food and Drug Administration approved revumenib as a single-agent therapy for the treatment of adults and pediatric patients with relapsed or refractory advanced acute leukemia...
Mapping blood system changes offers new hope for leukemia …
2024年12月6日 · Researchers at University of California San Diego School of Medicine and their colleagues have developed the first comprehensive map of the dramatic changes that take place in the blood system over...
Leukaemia - Latest research and news | Nature
6 天之前 · Leukaemia is a type of blood cancer, which starts in blood-forming tissue, such as the bone marrow, and causes large numbers of immature blood cells to be produced and enter the bloodstream....
New combinations and targeted therapies for acute myeloid leukemia …
2023年12月11日 · Acute myeloid leukemia is a cancer characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood and interfere with normal blood-cell production. It's one of the...